Harvard Study: Multivitamins Effective in Thwarting AIDS progress Thu, 1 Jul 2004 A report in the New England Journal of Medicine may be the first serious challenge to the current accepted treatment of people infected with the HIV-virus. Those expensive and toxic cocktails of AIDS drugs may not be the…
Ethical Violations / Investigations Today Congressional Investigations Office of Human Research Protections (OHRP) Letters of Determination: http://ohrp.osophs.dhhs.gov/detrm_letrs/lindex.htm Office of Protection from Research Risks* (OPRR) List of Compliance Oversight Investigations Resulting in Restrictions or Actions to federally licensed Institutions between 1990 – 2000. *Reorganized in 2000 as OHRP Mar 30: AHRP…
When Doctors Go to Class, Industry Often Foots the Bill – WSJ Fri, 6 Dec 2002 A front page article in The Wall Street Journal by Scott Hensley sheds further light on the corruption of medical ethics by focusing on a drug marketing ploy that is promoted as “continuing medical…
Statin-Cholesterol Guidelines–Industry influenced? Wed, 14 Jul 2004 Scientific journal editors are scrambling about how to react to bad publicity emanating from public disclosure that the scientific reports they have published are likely to be biased because the authors’ had financial ties to the companies whose drugs / devices they report…
Incentives to Pharma Companies but Health Care Leaders Voice Doubts on Smallpox Inoculations Thu, 30 Jan 2003 The New York Times reports (below) that serious doubts about the president’s smallpox vaccination plan emerged at a Senate hearing Wednesday. The Washington Post reports (below) that "The hearing illustrated the growing tensions…
Lilly's aggressive marketing of Xigris does indeed epitomize the worst ofthis industry's mission.
"Academic officials acknowledged in the published guidelines that Lilly gave more than 90 percent of $861,000 in grants for the campaign and medical recommendations. About a fifth of the 46 guidelines writers acknowledged previously taking money from Eli Lilly for speaking, consulting or research."
Once again, the New England Journal of Medicine (July 13, 2006) has had to eat crow after it published false and misleading clinical trial findings.
Medical journals are supposed to be vehicles for scientific give and take–not so, evidently, in journals of the American Psychiatric Association.
A ray of hope that might help cleanse medicine of its corrupt interaction with drug company marketers.
Two documented news reports provide evidence validating our charge that FDA officials and drug manufacturers.
“There is a crisis of credibility in medicine and science,” says Dr Joseph Sonnabend who, as a former virologist for the Medical Research Council and a retired Aids physician, has watched the basis for public confidence decline.
